ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for AUTL

Stock NameAutolus Therapeutics Ltd
TickerAUTL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05280R1005
LEI549300C0KZP8EYROLL02

Show aggregate AUTL holdings

News associated with AUTL

Analysts Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) PT at $9.12
Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) have received an average rating of “Buy” from the five analysts that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have updated their coverage […] - 2025-09-15 05:04:54
Brokerages Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Price Target at $9.12
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) has been given an average recommendation of “Buy” by the five brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock […] - 2025-08-19 02:16:53
Autolus Therapeutics (NASDAQ:AUTL) Trading Down 3.5% Following Analyst Downgrade
Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) fell 3.5% during trading on Wednesday after Wells Fargo & Company lowered their price target on the stock from $6.00 to $5.00. Wells Fargo & Company currently has an overweight rating on the stock. Autolus Therapeutics traded as low as $2.02 and last […] - 2025-08-15 02:52:49
Alps Advisors Inc. Sells 15,481 Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)
Alps Advisors Inc. reduced its stake in shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 7.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 199,709 shares of the company’s stock after selling 15,481 shares during the quarter. Alps Advisors […] - 2025-07-18 04:50:54
Vontobel Holding Ltd. Trims Stock Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)
Vontobel Holding Ltd. decreased its position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 5.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 138,783 shares of the company’s stock after selling 8,636 shares during the period. Vontobel Holding Ltd.’s […] - 2025-07-09 05:04:55
Exchange Traded Concepts LLC Has $108,000 Stake in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL)
Exchange Traded Concepts LLC grew its holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 67.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 69,993 shares of the company’s stock after acquiring an additional 28,127 shares during the period. Exchange Traded Concepts LLC’s holdings in Autolus Therapeutics were worth $108,000 […] - 2025-06-25 04:57:00
Two Sigma Advisers LP Acquires 15,400 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
Two Sigma Advisers LP grew its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 4.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 333,400 shares of the company’s stock after acquiring an additional 15,400 shares during the period. Two Sigma […] - 2025-06-03 05:00:53
OMERS ADMINISTRATION Corp Invests $85,000 in Autolus Therapeutics plc (NASDAQ:AUTL)
OMERS ADMINISTRATION Corp bought a new position in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,300 shares of the company’s stock, valued at approximately $85,000. A number of other […] - 2025-05-21 05:26:48
Brokerages Set Autolus Therapeutics plc (NASDAQ:AUTL) Price Target at $9.32
Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […] - 2025-05-13 02:14:55
Renaissance Technologies LLC Purchases 368,071 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
Renaissance Technologies LLC lifted its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 146.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 618,942 shares of the company’s stock after purchasing an additional 368,071 shares during the period. Renaissance Technologies LLC’s holdings in Autolus Therapeutics were worth $1,455,000 as of its most recent […] - 2025-04-29 04:44:58
Autolus Therapeutics (NASDAQ:AUTL) Given New $10.00 Price Target at Truist Financial
Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective trimmed by Truist Financial from $11.00 to $10.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and […] - 2025-04-02 04:14:47
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Rating of “Buy” from Analysts
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […] - 2025-03-26 03:53:00
Daiwa Securities Group Inc. Has $56,000 Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)
Daiwa Securities Group Inc. grew its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 55.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,743 shares of the company’s stock after purchasing an additional 8,479 shares during the quarter. Daiwa […] - 2025-03-18 05:42:52
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Bought by Handelsbanken Fonder AB
Handelsbanken Fonder AB boosted its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,300 shares of the company’s stock after buying an additional 17,300 shares during […] - 2025-03-04 06:46:54

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AUTL holdings

DateNumber of AUTL Shares HeldBase Market Value of AUTL SharesLocal Market Value of AUTL SharesChange in AUTL Shares HeldChange in AUTL Base ValueCurrent Price per AUTL Share HeldPrevious Price per AUTL Share Held
2026-01-15 (Thursday)129,751AUTL holding increased by 608USD 186,841AUTL holding increased by 3458USD 186,841608USD 3,458 USD 1.44 USD 1.42
2026-01-14 (Wednesday)129,143AUTL holding increased by 610USD 183,383AUTL holding increased by 7293USD 183,383610USD 7,293 USD 1.42 USD 1.37
2026-01-13 (Tuesday)128,533USD 176,090AUTL holding decreased by -16710USD 176,0900USD -16,710 USD 1.37 USD 1.5
2026-01-12 (Monday)128,533AUTL holding increased by 604USD 192,800AUTL holding decreased by -38751USD 192,800604USD -38,751 USD 1.5 USD 1.81
2026-01-09 (Friday)127,929AUTL holding increased by 906USD 231,551AUTL holding decreased by -11063USD 231,551906USD -11,063 USD 1.81 USD 1.91
2026-01-08 (Thursday)127,023USD 242,614AUTL holding decreased by -5081USD 242,6140USD -5,081 USD 1.91 USD 1.95
2026-01-07 (Wednesday)127,023AUTL holding increased by 604USD 247,695AUTL holding decreased by -5143USD 247,695604USD -5,143 USD 1.95 USD 2
2026-01-06 (Tuesday)126,419USD 252,838AUTL holding increased by 17699USD 252,8380USD 17,699 USD 2 USD 1.86
2026-01-05 (Monday)126,419USD 235,139AUTL holding decreased by -1265USD 235,1390USD -1,265 USD 1.86 USD 1.87
2026-01-02 (Friday)126,419AUTL holding increased by 302USD 236,404AUTL holding decreased by -14569USD 236,404302USD -14,569 USD 1.87 USD 1.99
2025-12-31 (Wednesday)126,117USD 250,973AUTL holding increased by 2523USD 250,9730USD 2,523 USD 1.99 USD 1.97
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AUTL by Blackrock for IE00BDZVHG35

Show aggregate share trades of AUTL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY6081.4551.400 1.405USD 855 1.98
2026-01-14BUY6101.4401.341 1.351USD 824 1.99
2026-01-12BUY6041.7901.490 1.520USD 918 1.99
2026-01-09BUY9061.9701.800 1.817USD 1,646 1.99
2026-01-07BUY6042.0701.940 1.953USD 1,180 1.99
2026-01-02BUY3022.0401.870 1.887USD 570 1.99
2025-12-30BUY3031.9901.872 1.883USD 571 1.99
2025-12-23SELL-3,6841.7201.635 1.643USD -6,055 2.00 Profit of 1,305 on sale
2025-12-19SELL-28,8941.6701.585 1.594USD -46,043 2.00 Profit of 11,768 on sale
2025-12-17SELL-1,8901.6401.560 1.568USD -2,964 2.00 Profit of 826 on sale
2025-12-16SELL-3781.6601.580 1.588USD -600 2.01 Profit of 158 on sale
2025-12-15BUY7561.6801.600 1.608USD 1,216 2.01
2025-12-11BUY7561.6051.535 1.542USD 1,166 2.01
2025-12-04BUY7,4601.6061.460 1.475USD 11,001 2.02
2025-12-02BUY5,6401.4001.310 1.319USD 7,439 2.03
2025-11-28BUY3761.4401.350 1.359USD 511 2.04
2025-11-26BUY1,1281.4001.320 1.328USD 1,498 2.04
2025-11-26BUY1,1281.4001.320 1.328USD 1,498 2.04
2025-11-25BUY1,8801.4901.310 1.328USD 2,497 2.05
2025-11-24BUY3761.2601.215 1.220USD 459 2.05
2025-11-20SELL-1,4961.3421.230 1.241USD -1,857 2.06 Profit of 1,223 on sale
2025-11-19BUY3731.3351.250 1.259USD 469 2.06
2025-11-18BUY2,2321.3201.280 1.284USD 2,866 2.07
2025-11-17BUY7441.3601.300 1.306USD 972 2.07
2025-11-14BUY3731.4001.245 1.261USD 470 2.07
2025-11-12BUY3711.3851.230 1.246USD 462 2.08
2025-11-10BUY3701.4001.320 1.328USD 491 2.09
2025-11-06BUY3701.3901.340 1.345USD 498 2.10
2025-11-04BUY3701.5351.400 1.413USD 523 2.11
2025-10-30BUY1,8601.5451.475 1.482USD 2,757 2.12
2025-10-29BUY7421.4601.560 1.550USD 1,150 2.12
2025-10-22SELL-1,4641.5501.645 1.635USD -2,394 2.14 Profit of 731 on sale
2025-10-20BUY7321.7001.720 1.718USD 1,258 2.14
2025-10-17BUY1,8251.6201.673 1.668USD 3,044 2.14
2025-10-15BUY2,8881.7201.755 1.751USD 5,058 2.15
2025-10-03BUY2,6041.6101.640 1.637USD 4,263 2.15
2025-10-02BUY3711.6101.699 1.690USD 627 2.16
2025-09-30BUY7421.6301.650 1.648USD 1,223 2.16
2025-09-26BUY7441.5601.590 1.587USD 1,181 2.17
2025-09-25BUY7441.5001.580 1.572USD 1,170 2.17
2025-09-18BUY3721.3601.370 1.369USD 509 2.18
2025-09-17BUY1,1191.2701.350 1.342USD 1,502 2.18
2025-07-17SELL-7242.4202.469 2.464USD -1,784 2.19 Loss of -202 on sale
2025-07-11SELL-2,9202.4702.520 2.515USD -7,344 2.18 Loss of -988 on sale
2025-07-02BUY20,0752.3502.440 2.431USD 48,802 2.17
2025-06-25BUY7282.3202.320 2.320USD 1,689 2.17
2025-06-11BUY7382.2402.370 2.357USD 1,739 2.17
2025-06-10BUY7382.3302.420 2.411USD 1,779 2.17
2025-06-04SELL-3712.0902.210 2.198USD -815 2.17 Loss of -12 on sale
2025-04-23BUY3711.5101.720 1.699USD 630 2.38
2025-04-10SELL-2,9761.1401.280 1.266USD -3,768 2.48 Profit of 3,621 on sale
2025-04-08SELL-3721.1801.400 1.378USD -513 2.51 Profit of 422 on sale
2025-04-07SELL-3711.3101.370 1.364USD -506 2.53 Profit of 431 on sale
2025-04-04SELL-1,8651.3301.510 1.492USD -2,783 2.54 Profit of 1,955 on sale
2025-04-01BUY16,0271.4101.629 1.607USD 25,757 2.57
2025-03-31SELL-9661.5501.630 1.622USD -1,567 2.58 Profit of 924 on sale
2025-03-14SELL-5,1681.8701.960 1.951USD -10,083 2.71 Profit of 3,917 on sale
2025-03-07SELL-6462.0102.080 2.073USD -1,339 2.77 Profit of 448 on sale
2025-03-04SELL-3231.8301.850 1.848USD -597 2.80 Profit of 309 on sale
2025-02-25BUY6461.7901.920 1.907USD 1,232 2.89
2025-02-19SELL-3232.0002.130 2.117USD -684 2.96 Profit of 273 on sale
2025-02-13BUY9661.9401.996 1.990USD 1,923 3.04
2025-02-12BUY3221.9601.980 1.978USD 637 3.06
2025-02-11BUY1,2881.9101.930 1.928USD 2,483 3.08
2024-12-30SELL-12,2912.2102.340 2.327USD -28,601 3.49 Profit of 14,270 on sale
2024-11-18SELL-5,2382.9903.250 3.224USD -16,887 3.97 Profit of 3,888 on sale
2024-11-08SELL-3473.7304.120 4.081USD -1,416 4.03 Loss of -18 on sale
2024-10-21SELL-3494.5204.788 4.761USD -1,662 0.00 Loss of -1,662 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AUTL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19326,08301,943,02916.8%
2025-09-18382,84902,825,87713.5%
2025-09-17516,77201,563,00933.1%
2025-09-16880,38003,583,12324.6%
2025-09-15961,51402,356,87240.8%
2025-09-121,507,04102,625,20157.4%
2025-09-11656,67703,996,03016.4%
2025-09-10508,10301,107,12145.9%
2025-09-09777,80507,543,05110.3%
2025-09-08301,8080702,55043.0%
2025-09-05815,10405,547,51914.7%
2025-09-04212,8050524,31540.6%
2025-09-03982,3053,3004,650,37621.1%
2025-09-02743,88304,764,44715.6%
2025-08-29514,9600909,86156.6%
2025-08-28634,55901,135,14755.9%
2025-08-27203,8640477,15642.7%
2025-08-26361,46701,538,08923.5%
2025-08-25315,60701,010,98631.2%
2025-08-22173,5170689,30825.2%
2025-08-21236,83401,399,67216.9%
2025-08-20251,2539,4131,250,78320.1%
2025-08-19345,8634,5011,494,24023.1%
2025-08-18219,25211,7952,069,61010.6%
2025-08-15521,92411,0778,500,0786.1%
2025-08-14429,20218,2171,267,38433.9%
2025-08-13814,21546,9002,001,04740.7%
2025-08-121,056,283174,2542,049,58351.5%
2025-08-11819,95511,0021,761,40146.6%
2025-08-08265,227904489,10454.2%
2025-08-07334,572483743,13545.0%
2025-08-06273,0131,038918,63729.7%
2025-08-05331,8824211,141,21629.1%
2025-08-04161,9741,8611,212,14313.4%
2025-08-01312,105600931,49933.5%
2025-07-31390,1252261,674,57123.3%
2025-07-30519,108400936,50655.4%
2025-07-29562,0565,3091,189,22447.3%
2025-07-28416,0970901,35346.2%
2025-07-25251,8552,400707,73035.6%
2025-07-24342,3962,8391,291,46326.5%
2025-07-23321,7340659,58348.8%
2025-07-22236,1452,274721,22732.7%
2025-07-21221,481684748,57429.6%
2025-07-18110,8793,304876,03012.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy